An Eradivir employee conducts research on the company’s EV25 influenza therapeutic. Research published in the Proceedings of the National Academy of Sciences shows EV25 acts faster and has a broader ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback